SNWV (SANUWAVE Health) Research & Development: $1.81 Mil (TTM As of Mar. 2026)


SNWV SANUWAVE Health Inc SNWV
38 GF Score
Price $7.68
GF Value $11.86
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is SANUWAVE Health Research & Development?

SANUWAVE Health SNWV -10.39% 38 Research & Development is $1.81 Mil as of Mar. 2026. GuruFocus rates SNWV with a GF Score™ of 38/100 and a GF Value™ of $11.86 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. SANUWAVE Health's Research & Development for the three months ended in Mar. 2026 was $0.66 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $1.81 Mil.

SANUWAVE Health  (NAS:SNWV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SANUWAVE Health Research & Development Related Terms

SANUWAVE Health Research & Development Historical Data

* Premium members only.

The historical data trend for SANUWAVE Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SANUWAVE Health Research & Development Chart

SANUWAVE Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 0.57 0.58 0.67 1.35

SANUWAVE Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.19 0.35 0.61 0.66
SNWV
38GF Score
SANUWAVE Health Inc SNWV
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SANUWAVE Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.81 Mil mean?
SANUWAVE Health (SNWV) has a Research & Development of $1.81 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on SANUWAVE Health and its competitors.
Is SANUWAVE Health's Research & Development too high?
SANUWAVE Health's current Research & Development is $1.81 Mil. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Research & Development compare to QTRX and CVRX?
SANUWAVE Health's Research & Development of $1.81 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on SANUWAVE Health and its competitors. SANUWAVE Health's current Research & Development is $1.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $11.86, compared to a current price of $7.68 — trading 35.2% below its estimated fair value. The current Research & Development is $1.81 Mil. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Research & Development is $1.81 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SANUWAVE Health (SNWV) Overvalued in 2026?

Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued. The current stock price of $7.68 is trading 35.2% below its estimated GF Value™ of $11.86. GuruFocus considers SANUWAVE Health to be Possible Value Trap.

Key valuation signals for SNWV:

  • Research & Development: $1.81 Mil
  • GF Value™: $11.86 vs. price of $7.68 (35.2% below fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SANUWAVE Health Business Description

Address 9600 W. 76th Street, Suite 118, Eden Prairie, MN, USA, 55344
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
38GF Score

Get the complete analysis for SNWV

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.68
Price
$11.86
GF Value